Frédéric Baron


Ontology type: schema:Person     


Person Info

NAME

Frédéric

SURNAME

Baron

Publications in SciGraph latest 50 shown

  • 2022-06-30 Outcome of human umbilical cord blood stem cell transplantation (CBT) for acute myeloid leukemia in patients achieving first complete remission after one versus two induction courses: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) in BONE MARROW TRANSPLANTATION
  • 2021-11-08 Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia in BONE MARROW TRANSPLANTATION
  • 2021-11-02 A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2021-10-24 Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2021-10-05 Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS) in BONE MARROW TRANSPLANTATION
  • 2021-07-10 Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT in BONE MARROW TRANSPLANTATION
  • 2021-06-25 Itacitinib prevents xenogeneic GVHD in humanized mice in BONE MARROW TRANSPLANTATION
  • 2021-05-03 Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2021-04-06 Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2021-03-04 High proportion of terminally differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2020-09-04 Better leukemia-free survival with allogeneic than with autologous HCT in AML patients with isolated trisomy 8: a study from the ALWP of the EBMT in BONE MARROW TRANSPLANTATION
  • 2020-07-28 Measurable residual disease (MRD) testing for acute leukemia in EBMT transplant centers: a survey on behalf of the ALWP of the EBMT in BONE MARROW TRANSPLANTATION
  • 2020-06-11 Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2019-08-07 Trends in the use of hematopoietic stem cell transplantation for adults with acute lymphoblastic leukemia in Europe: a report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) in ANNALS OF HEMATOLOGY
  • 2019-05-31 Hematopoietic stem cell transplantation with unrelated cord blood or haploidentical donor grafts in adult patients with secondary acute myeloid leukemia, a comparative study from Eurocord and the ALWP EBMT in BONE MARROW TRANSPLANTATION
  • 2019-04-12 Umbilical cord blood versus unrelated donor transplantation in adults with primary refractory or relapsed acute myeloid leukemia: a report from Eurocord, the Acute Leukemia Working Party and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the EBMT in BLOOD CANCER JOURNAL
  • 2018-11-01 Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) in BONE MARROW TRANSPLANTATION
  • 2018-08-30 Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2018-08-13 Post-remission strategies for the prevention of relapse following allogeneic hematopoietic cell transplantation for high-risk acute myeloid leukemia: expert review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2018-06-20 Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15–60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials in ANNALS OF HEMATOLOGY
  • 2018-01-12 Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2017-06-21 Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2017-01-25 Outcomes of UCB transplantation are comparable in FLT3+ AML: results of CIBMTR, EUROCORD and EBMT collaborative analysis in LEUKEMIA
  • 2016-07-04 Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2016-06-24 Comparative value of post-remission treatment in cytogenetically normal AML subclassified by NPM1 and FLT3-ITD allelic ratio in LEUKEMIA
  • 2016-06-13 Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT in BONE MARROW TRANSPLANTATION
  • 2016-03-14 Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time? in BONE MARROW TRANSPLANTATION
  • 2015-11-23 Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group in ANNALS OF HEMATOLOGY
  • 2015-10-06 Unrelated cord blood transplantation for adult patients with acute myeloid leukemia: higher incidence of acute graft-versus-host disease and lower survival in male patients transplanted with female unrelated cord blood—a report from Eurocord, the Acute Leukemia Working Party, and the Cord Blood Committee of the Cellular Therapy and Immunobiology Working Party of the European Group for Blood and Marrow Transplantation in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2015-09-26 Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013) in ANNALS OF HEMATOLOGY
  • 2015-09-24 Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG) in ANNALS OF HEMATOLOGY
  • 2015-05-14 Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation in CANCER IMMUNOLOGY, IMMUNOTHERAPY
  • 2015-02-06 Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society in JOURNAL OF HEMATOLOGY & ONCOLOGY
  • 2014-11-17 High numbers of mobilized CD34+ cells collected in AML in first remission are associated with high relapse risk irrespective of treatment with autologous peripheral blood SCT or autologous BMT in BONE MARROW TRANSPLANTATION
  • 2014-07-28 Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study in BONE MARROW TRANSPLANTATION
  • 2014-01-13 Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation in BONE MARROW TRANSPLANTATION
  • 2014-01-05 Thinking Out of the Box—New Approaches to Controlling GVHD in CURRENT HEMATOLOGIC MALIGNANCY REPORTS
  • 2012-05-22 Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation in LEUKEMIA
  • 2010-04 Mantle cell lymphoma. in SPRINGERREFERENCE
  • 2010-01-11 Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning in BONE MARROW TRANSPLANTATION
  • 2009-08-31 Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning in BONE MARROW TRANSPLANTATION
  • 2008-09-18 Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial in LEUKEMIA
  • 2008 Nonmyeloablative Transplantation in HEMATOPOIETIC STEM CELL TRANSPLANTATION
  • 2006-10-12 Transfusions after nonmyeloablative or reduced-intensity conditioning regimens in LEUKEMIA
  • 2006-07-27 Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning in LEUKEMIA
  • 2006-01-16 Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen in BONE MARROW TRANSPLANTATION
  • 2005-03-17 High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation in LEUKEMIA
  • 2004-07-29 Allogeneic hematopoietic cell transplantation as treatment for hematological malignancies: a review in SEMINARS IN IMMUNOPATHOLOGY
  • 2003-10-01 Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC in BONE MARROW TRANSPLANTATION
  • 1998-07-01 Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.411374.4", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.168010.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.223827.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410425.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412134.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7605.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5288.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413919.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.424470.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.252890.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.34477.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.18887.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.270240.3", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5596.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.30760.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14925.3b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4861.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413914.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.9647.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.16549.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477771.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Baron", 
        "givenName": "Fr\u00e9d\u00e9ric", 
        "id": "sg:person.0701462103.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701462103.33"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-10-01T07:17", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/person/person_740.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0701462103.33'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0701462103.33'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0701462103.33'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0701462103.33'


     

    This table displays all metadata directly associated to this object as RDF triples.

    56 TRIPLES      10 PREDICATES      31 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0701462103.33 schema:affiliation Naa1b65bccef04f59bad6071b83559020
    2 grid-institutes:grid.14925.3b
    3 grid-institutes:grid.16549.3f
    4 grid-institutes:grid.168010.e
    5 grid-institutes:grid.18887.3e
    6 grid-institutes:grid.223827.e
    7 grid-institutes:grid.252890.4
    8 grid-institutes:grid.270240.3
    9 grid-institutes:grid.30760.32
    10 grid-institutes:grid.34477.33
    11 grid-institutes:grid.410425.6
    12 grid-institutes:grid.412134.1
    13 grid-institutes:grid.413914.a
    14 grid-institutes:grid.413919.7
    15 grid-institutes:grid.424470.1
    16 grid-institutes:grid.477771.5
    17 grid-institutes:grid.4861.b
    18 grid-institutes:grid.5288.7
    19 grid-institutes:grid.5596.f
    20 grid-institutes:grid.7605.4
    21 grid-institutes:grid.9647.c
    22 schema:familyName Baron
    23 schema:givenName Frédéric
    24 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0701462103.33
    25 schema:sdDatePublished 2022-10-01T07:17
    26 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    27 schema:sdPublisher N3b875febc94e4ae8af9138ed25d12540
    28 sgo:license sg:explorer/license/
    29 sgo:sdDataset persons
    30 rdf:type schema:Person
    31 N3b875febc94e4ae8af9138ed25d12540 schema:name Springer Nature - SN SciGraph project
    32 rdf:type schema:Organization
    33 Naa1b65bccef04f59bad6071b83559020 schema:affiliation grid-institutes:grid.411374.4
    34 sgo:isCurrent true
    35 rdf:type schema:OrganizationRole
    36 grid-institutes:grid.14925.3b schema:Organization
    37 grid-institutes:grid.16549.3f schema:Organization
    38 grid-institutes:grid.168010.e schema:Organization
    39 grid-institutes:grid.18887.3e schema:Organization
    40 grid-institutes:grid.223827.e schema:Organization
    41 grid-institutes:grid.252890.4 schema:Organization
    42 grid-institutes:grid.270240.3 schema:Organization
    43 grid-institutes:grid.30760.32 schema:Organization
    44 grid-institutes:grid.34477.33 schema:Organization
    45 grid-institutes:grid.410425.6 schema:Organization
    46 grid-institutes:grid.411374.4 schema:Organization
    47 grid-institutes:grid.412134.1 schema:Organization
    48 grid-institutes:grid.413914.a schema:Organization
    49 grid-institutes:grid.413919.7 schema:Organization
    50 grid-institutes:grid.424470.1 schema:Organization
    51 grid-institutes:grid.477771.5 schema:Organization
    52 grid-institutes:grid.4861.b schema:Organization
    53 grid-institutes:grid.5288.7 schema:Organization
    54 grid-institutes:grid.5596.f schema:Organization
    55 grid-institutes:grid.7605.4 schema:Organization
    56 grid-institutes:grid.9647.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...